Alchemia (ASX:ACL) will in-license two early-stage cancer drug candidates originating from CTx research. [ + ]

Medical and Scientific Technologies Supplier Advocate Dr Greg Roger is seeking case studies to promote and raise awareness of the capabilities of Australian SMEs in the medical and scientific technology field, facilitate collaboration opportunities and share lessons learned. [ + ]

Researchers from Finland and Estonia have discovered novel biological markers that indicate an individual's risk of dying from any disease in the near future. [ + ]

Scientists at the Royal Botanic Garden, Sydney, have adapted innovative genomic techniques that allow the accurate identification of the exact origin of plant material. [ + ]

Scientists at the US Department of Energy's Ames Laboratory are revealing the mysteries of new materials using ultrafast laser spectroscopy - a technique in which many quick images reveal subtle movements and changes inside the materials. [ + ]

Singing is almost as common in female birds as in males, challenging long-held theories about it being an exclusively male trait. [ + ]

Neuren's (ASX:NEU) cash balance of $25m should be enough to fund key clinical trials of neurological drug candidate NNZ-2566 through to the expected receipt of licensing revenue in 2015, Bell Potter says. [ + ]

WEHI joins international partnership to help eliminate malaria. [ + ]

Nobel laureate Dr James D Watson has released a new hypothesis on the causation of type 2 diabetes. [ + ]

ANSTO's CEO, Dr Adrian (Adi) Paterson, has been reappointed and businessman James McDowell has joined the ANSTO board. [ + ]

Building on the strategic plan that was presented at the AusBiotech national conference in November by AusBiotech Chair Dr Deborah Rathjen, the organisation is continuing its call for further tax reform in Australia. [ + ]

Laurence Gozlan, Nathan Drona and Dr Geert Cauwenbergh have joined Phosphagenics (ASX:POH) as non-executive directors. [ + ]

Fibrotech Therapeutics has been awarded patents in the US and Canada covering its portfolio of antifibrotic drug candidates. [ + ]

Researchers from the University of Chicago Medicine have found that the process of genome analysis, which could typically take many months, can be rapidly accelerated. [ + ]

The 2014 Australia to US Fellowships are open to applications. [ + ]